Landauer Inc.
LDR
New York Stock Exchange67.20
USD
-0.10
- -
Landauer Inc.
LDR
(New York Stock Exchange)
Recent
price
67.20
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Landauer Inc. (LDR) provides integrated radiation safety products, dosimetry solutions, and medical physics consulting services to healthcare providers, industrial facilities, military, and first responders worldwide. Founded in 1954 and headquartered in Glenwood, Illinois, the company offers occupational dosimetry including Luxel+ dosimeters, readers, and the myLDR client portal; medical dosimetry with secondary dose verification; imaging physics services such as equipment performance testing, nuclear medicine surveys, and accreditation support; on-site and remote compliance services encompassing radiation protection programs, shielding design, and staff education through LANDAUER Academy; and packaged toolsets with ancillary reports for radiation monitoring in hospitals, cancer treatment centers, imaging centers, dental and veterinary offices, and energy sectors. It operates dosimetry laboratories in multiple countries utilizing proprietary optically stimulated luminescence technology for accurate occupational, environmental, and patient radiation dose measurement and analysis. In recent developments, Landauer secured national group purchasing agreements with Premier Inc. effective September 1, 2025, enhancing access to its radiation safety and compliance expertise for thousands of U.S. hospitals and health systems; launched the ALARA Service for myLDR on July 2, 2025, providing a digital workflow for managing ALARA notifications and record-keeping; and introduced the Signature Suite digital compliance workflow for myLDR in September 2024 to streamline inspection readiness.
More high-grade assays pave way for resource at Golden Eye
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Builders FirstSource, Inc. (NYSE:LDR) and Encourages Investors to Contact the Firm
6 signs you need to end your long distance relationship
American Brachytherapy Society LDR Prostate Brachytherapy Treatment Consensus Paper Recognizes Isoray's Cesium-131